Skip to main content
. 2022 Nov 23;12:1043177. doi: 10.3389/fonc.2022.1043177

Table 1.

Clinical features of KRAS-mutated LUAD patients.

Features Variables No. (%)
Age < 60 19 (53)
60 17 (47)
Gender Male 20 (56)
Female 16 (44)
Pathological stage Early (T1-T2) 15 (42)
Advanced (T3-T4) 21 (58)
Lymphatic metastasis Yes 10 (28)
No 26 (72)
KRAS Status KRAS Wild 28 (78)
KRAS Mutation 8 (22)